Showing results (241-250 of 384) with videos related to
Sort By:
Pageof 39
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 10, 2021
Gastrointestinal leiomyosarcoma demonstrate a predilection for distant recurrence and poor response to systemic treatmentsAlannah Smrke, Charlotte Benson, Dirk C Strauss, et al.Medical Oncology (Northwood, London, England)|September 7, 2018
Clinical Characteristics and efficacy of chemotherapy in sclerosing epithelioid fibrosarcomaWinston Chew, Charlotte Benson, Khin Thway, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
A phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumorsDebashis Sarker, Rhoda Molife, T R Jeffrey Evans, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
A phase I study of a new nucleoside analogue, OSI-7836, using two administration schedules in patients with advanced solid malignanciesChooi P Lee, Maja J A de Jonge, Anne E O'Donnell, et al.The American Journal of Surgical Pathology|May 16, 2017
The Adequacy of Core Biopsy in the Assessment of Smooth Muscle Neoplasms of Soft Tissues: Implications for Treatment and PrognosisNina Schneider, Dirk C Strauss, Myles J Smith, et al.Journal of Clinical Pathology|December 15, 2010
Nuclear NF-κB/p65 expression and response to neoadjuvant chemotherapy in breast cancerRobin L Jones, Federico Rojo, Roger A'Hern, et al.Communications Medicine|May 18, 2024
Proteomic features of soft tissue tumours in adolescents and young adultsYuen Bun Tam, Kaan Low, Hari Ps, et al.Cancers|April 12, 2022
Health-Related Quality of Life and Side Effects in Gastrointestinal Stromal Tumor (GIST) Patients Treated with Tyrosine Kinase Inhibitors: A Systematic Review of the LiteratureDeborah van de Wal, Mai Elie, Axel Le Cesne, et al.Anticancer Research|December 29, 2018
Gemcitabine Re-challenge in Metastatic Soft Tissue Sarcomas: A Therapeutic Option for Selected PatientsAna Sebio, Anastasia Constantinidou, Charlotte Benson, et al.Nature Communications|January 29, 2026
Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trialRobin L Jones, Roman Groisberg, Jean-Yves Blay, et al.Pageof 39